Stocktoria

UroGen Pharma Ltd. URGN

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2017-05-04 · LEI

UroGen Pharma Ltd. statistics & valuation

Market cap$1.6B
P / S14.2×
Net margin-139.8%
FCF margin-148.2%
Net debt$14.3M
Enterprise value USD$1.6B
Earnings yield EBIT/EV-7.9%
Return on capital-81.1%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-11.10% -245.20% -6707.20% -584144.40% -1088.90% -230.70% -170.60% -123.60% -140.40% -139.80% 2016201720182019202020212022202320242025
Gross margin (%)
99.80% 92.60% -59.80% 100.00% 91.40% 89.30% 88.10% 88.70% 90.20% 88.70% 2016201720182019202020212022202320242025
Operating margin (%)
4.60% -244.50% -6842.20% -608211.10% -1074.20% -192.10% -122.80% -79.20% -107.10% -113.70% 2016201720182019202020212022202320242025
Return on equity (%)
-11.90% -29.20% -84.00% -58.30% -133.30% -1317.20% 2016201720182019202020212022202320242025
Shares outstanding
2.3M 13.8M 16.2M 21.0M 22.2M 22.5M 23.1M 32.5M 42.9M 48.4M 2016201720182019202020212022202320242025
Net debt ($)
-$44.4M $42.1M $3.5M -$50.3M $14.3M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-8.40% -26.50% -73.10% -52.00% -105.30% -92.50% -80.90% -57.30% -44.40% -76.60% 2016201720182019202020212022202320242025
Free cash flow margin (%)
19.90% -120.60% -3359.40% -396344.40% -907.70% -178.30% -136.40% -92.60% -107.40% -148.20% 2016201720182019202020212022202320242025
Debt / equity (×)
0.00× 2016201720182019202020212022202320242025
EPS ($)
2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin88.7%90.2%88.7%88.1%89.3%91.4%100.0%-59.8%92.6%99.8%
Operating margin-113.7%-107.1%-79.2%-122.8%-192.1%-1074.2%-608211.1%-6842.2%-244.5%4.6%
Net margin-139.8%-140.4%-123.6%-170.6%-230.7%-1088.9%-584144.4%-6707.2%-245.2%-11.1%
FCF margin-148.2%-107.4%-92.6%-136.4%-178.3%-907.7%-396344.4%-3359.4%-120.6%19.9%
Return on assets-76.6%-44.4%-57.3%-80.9%-92.5%-105.3%-52.0%-73.1%-26.5%-8.4%
Return on equity145.5%1441.3%156.8%122.9%-1317.2%-133.3%-58.3%-84.0%-29.2%-11.9%
Debt / equity-1.19×-13.83×-1.51×-1.09×0.00×—————
Current ratio4.016.015.425.395.115.397.637.5910.597.03

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.